The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer

Cancer Control. 2023 Jan-Dec:30:10732748231206929. doi: 10.1177/10732748231206929.

Abstract

Purpose: This study aims to determine the optimal cut-off value of Ki-67 to better predict the recurrence of early low-risk endometrial cancer (EC).

Methods: Seven hundred and forty-eight patients diagnosed with low-risk EC from West China Second Hospital of Sichuan University and the First Affiliated Hospital of Chongqing Medical University were retrospectively analyzed. The receiver operating characteristic curve (ROC) and Youden index were used to calculate the optimal cut-off value of Ki-67 expression. The clinicopathological indexes between two groups divided by cut-off value of Ki-67 were compared. The univariate and multivariate regression analyses were performed to investigate risk factors connected to the recurrence of early low-risk EC. The survival analysis was shown in Kaplan-Meier curve.

Result: Thirty-three patients were detected with tumor recurrence after primary surgery (4.4%); 33% was the optimal cut-off value of the Ki-67 index. A high Ki-67 was significantly associated with age (P = .002), myometrial invasion (P < .001), and the expression of P53 (P = .007). The multivariate regression analysis verified that Ki67 ≥ 33% was an independent prognostic factor for predicting recurrence. The recurrence-free survival (RFS) and the overall survival (OS) in high Ki-67 group was significantly lower than that in low Ki-67 group (P < .001 and P = .029, respectively). The prognostic values of ER, PR, and P53 in combination with Ki-67 were superior to each single predictor.

Conclusions: The optimal cut-off value of Ki-67 for predicting recurrence is 33%, which quantitatively defines the specific value of Ki-67 that causes high-risk recurrence in early low-risk EC.

Keywords: Ki-67; cut-off value; early low-risk endometrial cancer; recurrence; survival.

MeSH terms

  • Endometrial Neoplasms*
  • Female
  • Humans
  • Ki-67 Antigen / metabolism
  • Neoplasm Recurrence, Local
  • Prognosis
  • Retrospective Studies
  • Tumor Suppressor Protein p53*

Substances

  • Ki-67 Antigen
  • Tumor Suppressor Protein p53